Healthtech Series B Investors & VC Firms
1028 firms in this list, with a median first check of $540K. 256 of them lead rounds. Generated from verified public data and updated continuously.
Inspired Capital
New YorkPre-Seed–Growth$500K – $20M
20 people
Next Coast Ventures
AustinSeed–Series B$2M – $4M
15 people
Casdin Capital
New YorkSeed–Series C
38 people
Bain Capital Life Sciences
BostonSeries B–Late Stage
31 people
Manta Ray Ventures
LondonPre-Seed–Growth
8 people
S32
Palo AltoSeries A–Late Stage
30 people
Johnson & Johnson Innovation – JJDC
New BrunswickSeed–Growth
42 people
Investible Climate Tech Fund
SydneyPre-Seed–Series B$330K
20 people
Nazca
Mexico CityPre-Seed–Late Stage
32 people
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
16 people
Tencent Holdings
ShenzhenSeed–Series C
28 people
Taiwania Capital
TaipeiSeed–Growth
49 people
Presidio Ventures
Silicon ValleySeed–Growth$500K – $5M
26 people
Sozo Ventures
Redwood CityPre-Seed–Late Stage
29 people
Eurazeo
ParisSeed–Late Stage
35 people
Vida Ventures
Los AngelesPre-Seed–Late Stage
44 people
Nauta Capital
BarcelonaPre-Seed–Series B$1.1M – $5.5M
24 people
OneVentures
SydneySeed–Growth$3.3M – $13.2M
40 people
Coral Capital
TokyoPre-Seed–Growth$500K – $5M
24 people
Tenaya Capital
Palo AltoSeries A–Growth$5M – $10M
8 people
redalpine
ZugSeed–Growth$108K – $2.2M
28 people
b2venture
BerlinPre-Seed–Series B$270K – $5.4M
36 people
Teachers' Venture Growth
TorontoSeries B–Late Stage$50M – $250M
40 people
Lightstone Ventures
Portola ValleyPre-Seed–Series C
31 people
Related lists
Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Series B Investors & VC Firms (2946)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Series B Investors & VC Firms in North America (1736)Series B Investors & VC Firms in United States (1571)Healthtech Pre-Seed Investors & VC Firms (1468)Healthtech Investors & VC Firms in Europe (1358)
Data sourced from public filings and firms' own websites — see our methodology.















































































































